Biotech - Press Releases

Date	Title	Company
24-Dec-2019	Venous Stents Market	Fior Market Research LLP
24-Dec-2019	EpiVax Announces Record Year for Growth in 2019 and Sets New Milestones for 2020	EpiVax, Inc.
23-Dec-2019	TEQ: Plastique brings cleanroom packaging manufacturing closer to home	Plastique
23-Dec-2019	Abeona Therapeutics Announces Public Offering of Common Stock and Pre Funded Warrants	Abeona Therapeutics
23-Dec-2019	Nanoform files for GMP certification	Nanoform
23-Dec-2019	Abeona Therapeutics Receives European Medicines Agency PRIME Designation for ABO-102 Gene Therapy in MPS IIIA	Abeona Therapeutics Inc
23-Dec-2019	AstraZeneca’s triple-combination therapy approved in China for patients with COPD	AstraZeneca
23-Dec-2019	ViiV Healthcare receives complete response letter from US FDA for use of investigational cabotegravir and rilpivirine long-acting regimen in the treatment of HIV	ViiV Healthcare
23-Dec-2019	Roche enters licensing agreement with Sarepta Therapeutics to improve the lives of patients living with Duchenne muscular dystrophy	Roche
23-Dec-2019	Enhertu (trastuzumab deruxtecan) approved in the US for HER2-positive unresectable or metastatic breast cancer following two or more prior anti-HER2 based regimens	AstraZeneca
23-Dec-2019	U.S. FDA APPROVES EISAI’S DAYVIGO™ (LEMBOREXANT) FOR TREATMENT OF INSOMNIA IN ADULT PATIENTS	Eisai Co., Ltd
23-Dec-2019	Akari Therapeutics Announces Initiation of Pivotal Phase III Trial of Nomacopan in Pediatric Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA) Following the Opening of its IND	Akari Therapeutics, Plc
23-Dec-2019	Theravance Biopharma and Pfizer Inc. Enter Global License Agreement for Skin-Targeted, Locally-Acting Pan-Janus Kinase (JAK) Inhibitor Program	Theravance Biopharma, Inc.
23-Dec-2019	Anixa Biosciences to Present at Biotech Showcase 2020	Anixa Biosciences, Inc.
23-Dec-2019	Hoth Therapeutics, Inc. Issues 2019 Shareholder Letter	Hoth Therapeutics, Inc.
23-Dec-2019	The Valens Company Announces New Extraction, White Label and Supply Agreements and Updates OTCQX Ticker to 'VLNCF'	Valens GroWorks Corp.
23-Dec-2019	Cellect Biotechnology Receives Approval for U.S. Clinical Trial	Cellect Biotechnology Ltd.
23-Dec-2019	Mallinckrodt to Present at the 38th Annual J.P. Morgan Healthcare Conference	Mallinckrodt plc
23-Dec-2019	RepliCel Announces its Incoming Board of Directors	RepliCel Life Sciences Inc.
23-Dec-2019	BioInvent Announces Selection of Second Target and Extension of the Research Collaboration and License Agreement With Pfizer Inc.	BioInvent